murmuration of birds

All articles

Case Study

MFP effectuation: Preventing a duplicate 340B discount

in Case studies

Federal and state policy

Webinar: After the midterms: What do the results mean for drug pricing, Medicare, and public health?

in Thought leadershipby Elif Alyanak; Lisa Joldersma; Matt Kazan
Oct 14, 2026

How MFN pricing in the final GLOBE Model will affect beneficiary OOP costs

in Thought leadershipby Marina Thornton, Kolton Gustafson, Amanda Tripp, Chelsea Mackiewicz
Oct 9, 2026

Women's health

Women’s Health Initiative

in Thought leadership
Oct 8, 2026

Coverage and payment

Medicare’s proposed IPCI and modifier 25 changes could reduce dermatology reimbursement

in Thought leadershipby Maddi Davidson, Vivian Ting
Oct 7, 2026

Wendy Jory, PhD, MBA, global and US pricing and market access leader, joins Avalere Health as Senior Vice President, Market Access

in News
Oct 6, 2026

Drug pricing and affordability

Beyond Medicare: How Part B drug negotiation may reshape commercial reimbursement

in Thought leadershipby Brooke Fruman, Kolton Gustafson, Maddi Davidson, Markas Elias
Oct 2, 2026

Coverage and payment

PDP instability accelerates in 2027 as plan options shrink and premiums rise

in Thought leadershipby Kylie Stengel, Robin Duddy-Tenbrunsel, Kirsten Stryker Blasch, Amanda Tripp, Yiwen He
Sep 30, 2026

Healthcare delivery and transformation

Beyond dispensing: The expanding role of the pharmacist

in Thought leadershipby Kirsten Stryker Blasch, Marina Thornton, Robin Duddy-Tenbrunsel
Sep 30, 2026

Women's health

Meet Avalere Health at WHIS

in Thought leadership
Sep 21, 2026